跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 美全
教授
,
藥物科學學科
合聘教授
,
生藥學研究所
合聘教授
,
新藥研發產業博士學位學程
合聘教授
,
臨床基因體學暨蛋白質體學碩士學位學程
合聘教授
,
中草藥臨床藥物研發博士學位學程
成員
,
臺北醫學大學胸腔醫學研究中心
https://orcid.org/0000-0002-2058-3413
電子郵件
mcchen1250
tmu.edu
tw
h-index
848
引文
17
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2011
2024
每年研究成果
概覽
指紋
網路
專案
(16)
研究成果
(46)
資料集
(1)
類似的個人檔案
(8)
指紋
查看啟用 Mei-Chuan Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Histone Deacetylase 6
100%
Malignant Neoplasm
91%
IC50
76%
Non Small Cell Lung Cancer
75%
Colorectal Cancer
62%
Antiproliferative Activity
58%
Histone Deacetylase
53%
Protein P53
51%
Histone Deacetylase Inhibitor
51%
Hydroxamic Acid
50%
Anticarcinogen
45%
Colorectal Carcinoma
36%
STAT3 Protein
35%
Lung Cancer
32%
Antitumor Activity
30%
Sulfonyl
28%
Prostate Cancer
28%
Caspase 3
27%
Flavonoid
26%
Epidermal Growth Factor Receptor
25%
Programmed Death 1 Ligand 1
24%
Cytotoxicity
23%
Tubulin
23%
Drug Development
22%
Ovary Cancer
22%
Anilide
22%
2,5-Dimethoxy-4-iodoamphetamine
22%
Medicinal Fungus
22%
Isoptera
22%
Antimitotic Agent
22%
Pharmaceutical Chemistry
22%
Heat Shock Protein 90
22%
Reactive Oxygen Metabolite
22%
DNA Topoisomerase (ATP Hydrolysing)
22%
Bladder Cancer
22%
Neoplasm
22%
Histone Deacetylase 1
20%
Western Blot
20%
Tumor Growth
20%
Synergism
17%
Amino Acid
17%
Caspase
17%
Histone Deacetylase 2
15%
Resorcinol
14%
Liver Cell Carcinoma
12%
Structure Activity Relationship
12%
Carboxamide
12%
Phosphotransferase
11%
Pancreas Cancer
11%
Piperazinedione
11%
Medicine and Dentistry
Programmed Cell Death
50%
Cancer Cell
46%
STAT3 Protein
34%
Mitosis Inhibition
34%
Non Small Cell Lung Cancer
28%
Anticarcinogen
28%
Antimitotic Agent
22%
Sulfonyl
22%
4 Iodo 2,5 Dimethoxyamphetamine
22%
Ovarian Cancer
22%
Protein P53
22%
Autophagy
22%
IC50
22%
In Vitro
21%
Cell Cycle M Phase
15%
Tubulin
15%
Mitotic Inhibitor
15%
Antiproliferative Activity
15%
Xenograft
14%
Cell Death
13%
Colorectal Carcinoma
13%
Cancer Therapy
13%
Cell Cycle
11%
Cell Viability
11%
Phosphotransferase
11%
Benzamide Derivative
11%
Reactive Oxygen Species
11%
Colorectal Cancer
11%
Amino Terminal Sequence
11%
Pancreas Cancer
11%
Pancreas Carcinoma
11%
Cancer Cell Line
11%
Vascular-Targeting Agent
11%
Capillary
11%
Amino Acid
11%
Cisplatin
11%
Histone Deacetylase
11%
Flavonoid
11%
Mitogen-Activated Protein Kinase
11%
Piperazinedione
11%
Organoid
11%
Prostate Cancer
11%
Docetaxel
11%
Poly ADP Ribose Polymerase
9%
Microtubule Assembly
9%
Cell Line
7%
Therapeutic Agent
7%
Caspase
7%
Cell Growth
6%
N [2 [(4 Hydroxyphenyl)amino] 3 Pyridinyl] 4 Methoxybenzenesulfonamide
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
70%
Histone Deacetylase
51%
Cell Death
32%
HDAC6
30%
Autophagy
29%
P53
25%
Anticancer
22%
DNA Gyrase
22%
IC50
22%
Antineoplastic Activity
18%
Cell Growth
18%
Isoform
13%
Epidermal Growth Factor Receptor
13%
Growth Inhibition
12%
Kruppel Like Factor 6
11%
Mitosis Inhibition
11%
Dynamics
11%
Polyploid
11%
Erlotinib
11%
Ribonucleotide Reductase Inhibitor
11%
Epigenetics
11%
BRCA1
11%
Tumor Suppressor Gene
11%
DNA Repair
11%
Gene Expression
11%
Caspase
11%
Heat Shock Protein
11%
Tumor Necrosis Factor
11%
Programmed Cell Death
11%
Caspase 3
11%
DNA Damage
10%
Histone H3
8%
GI50
7%
DNA Damage Response
7%
Survival Rate
7%
Cell Viability
7%
Dephosphorylation
6%
down Regulation
6%
Apoptosis
6%
Signal Transduction
5%
Cancer Mortality
5%
Histone-Modifying Enzymes
5%
Promoter Region
5%
Caspase 8
5%
Fibroblast Growth Factor Receptor 3
5%
Immune Checkpoints
5%